(MDLZ) Mondelez International - Ratings and Ratios
Biscuits, Chocolates, Snacks, Beverages, Cookies, Crackers
MDLZ EPS (Earnings per Share)
MDLZ Revenue
Description: MDLZ Mondelez International
Mondelez International Inc (NASDAQ:MDLZ) is a global snack food and beverage company with a diverse portfolio of brands, including Oreo, Cadbury Dairy Milk, and CLIF Bar, operating in over 150 countries across Latin America, North America, Asia, Europe, the Middle East, and Africa.
The companys product offerings span biscuits, chocolates, gums, candies, cheese, and grocery products, which are sold through various channels, including direct store delivery, e-retail platforms, and company-owned websites. Mondelez has a strong presence in the global snack food market, with a mix of legacy brands and newer acquisitions.
From a financial perspective, Mondelez has demonstrated stable revenue growth, with a current market capitalization of approximately $89 billion. Key performance indicators (KPIs) such as revenue growth rate, operating margin, and return on equity (RoE) are crucial in evaluating the companys performance. Mondelezs RoE of 13.31% indicates a relatively stable return on shareholder equity. Additionally, the companys dividend yield and payout ratio are also important metrics to consider, as they reflect the companys ability to generate cash and return value to shareholders.
To further analyze Mondelezs performance, other relevant KPIs include gross margin, operating cash flow, and debt-to-equity ratio. A gross margin analysis can help assess the companys pricing power and cost management, while operating cash flow can provide insights into the companys ability to generate cash from its core operations. A debt-to-equity ratio analysis can help evaluate the companys capital structure and risk profile.
MDLZ Stock Overview
| Market Cap in USD | 79,888m |
| Sub-Industry | Packaged Foods & Meats |
| IPO / Inception | 2001-06-13 |
MDLZ Stock Ratings
| Growth Rating | 18.3% |
| Fundamental | 58.8% |
| Dividend Rating | 73.8% |
| Return 12m vs S&P 500 | -28.1% |
| Analyst Rating | 4.07 of 5 |
MDLZ Dividends
| Dividend Yield 12m | 3.73% |
| Yield on Cost 5y | 4.75% |
| Annual Growth 5y | 8.33% |
| Payout Consistency | 98.0% |
| Payout Ratio | 61.4% |
MDLZ Growth Ratios
| Growth Correlation 3m | -73.6% |
| Growth Correlation 12m | -9.4% |
| Growth Correlation 5y | 73.9% |
| CAGR 5y | 4.26% |
| CAGR/Max DD 3y | 0.17 |
| CAGR/Mean DD 3y | 0.55 |
| Sharpe Ratio 12m | -1.11 |
| Alpha | 0.00 |
| Beta | 0.975 |
| Volatility | 21.07% |
| Current Volume | 8363.8k |
| Average Volume 20d | 6423.9k |
| Stop Loss | 60.8 (-3%) |
| Signal | -0.51 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (3.64b TTM) > 0 and > 6% of Revenue (6% = 2.23b TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -0.90pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -19.22% (prev -20.18%; Δ 0.96pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 4.16b > Net Income 3.64b (YES >=105%, WARN >=100%) |
| Net Debt (20.00b) to EBITDA (6.00b) ratio: 3.33 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.64 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.30b) change vs 12m ago -3.64% (target <= -2.0% for YES) |
| Gross Margin 32.49% (prev 40.34%; Δ -7.85pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 51.49% (prev 49.22%; Δ 2.28pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.59 (EBITDA TTM 6.00b / Interest Expense TTM 544.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.02
| (A) -0.10 = (Total Current Assets 12.75b - Total Current Liabilities 19.88b) / Total Assets 71.02b |
| (B) 0.51 = Retained Earnings (Balance) 36.29b / Total Assets 71.02b |
| (C) 0.06 = EBIT TTM 4.67b / Avg Total Assets 72.06b |
| (D) 0.55 = Book Value of Equity 24.73b / Total Liabilities 44.77b |
| Total Rating: 2.02 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 58.78
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 2.88% = 1.44 |
| 3. FCF Margin 7.71% = 1.93 |
| 4. Debt/Equity 0.80 = 2.19 |
| 5. Debt/Ebitda 3.48 = -2.29 |
| 6. ROIC - WACC -0.05% = -0.07 |
| 7. RoE 13.64% = 1.14 |
| 8. Rev. Trend 56.97% = 4.27 |
| 9. EPS Trend -6.50% = -0.32 |
What is the price of MDLZ shares?
Over the past week, the price has changed by +0.21%, over one month by +1.39%, over three months by -6.06% and over the past year by -14.61%.
Is Mondelez International a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MDLZ is around 57.27 USD . This means that MDLZ is currently overvalued and has a potential downside of -8.66%.
Is MDLZ a buy, sell or hold?
- Strong Buy: 11
- Buy: 8
- Hold: 9
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the MDLZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 74.4 | 18.7% |
| Analysts Target Price | 74.4 | 18.7% |
| ValueRay Target Price | 63.4 | 1.1% |
Last update: 2025-09-09 04:42
MDLZ Fundamental Data Overview
CCE Cash And Equivalents = 1.50b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 22.6154
P/E Forward = 18.7266
P/S = 2.153
P/B = 3.05
P/EG = 4.6151
Beta = 0.454
Revenue TTM = 37.10b USD
EBIT TTM = 4.67b USD
EBITDA TTM = 6.00b USD
Long Term Debt = 18.12b USD (from longTermDebt, last quarter)
Short Term Debt = 2.77b USD (from shortTermDebt, last quarter)
Debt = 20.89b USD (Calculated: Short Term 2.77b + Long Term 18.12b)
Net Debt = 20.00b USD (from netDebt column, last quarter)
Enterprise Value = 99.27b USD (79.89b + Debt 20.89b - CCE 1.50b)
Interest Coverage Ratio = 8.59 (Ebit TTM 4.67b / Interest Expense TTM 544.0m)
FCF Yield = 2.88% (FCF TTM 2.86b / Enterprise Value 99.27b)
FCF Margin = 7.71% (FCF TTM 2.86b / Revenue TTM 37.10b)
Net Margin = 9.81% (Net Income TTM 3.64b / Revenue TTM 37.10b)
Gross Margin = 32.49% ((Revenue TTM 37.10b - Cost of Revenue TTM 25.05b) / Revenue TTM)
Tobins Q-Ratio = 4.01 (Enterprise Value 99.27b / Book Value Of Equity 24.73b)
Interest Expense / Debt = 0.72% (Interest Expense 151.0m / Debt 20.89b)
Taxrate = 24.11% (1.47b / 6.09b)
NOPAT = 3.55b (EBIT 4.67b * (1 - 24.11%))
Current Ratio = 0.64 (Total Current Assets 12.75b / Total Current Liabilities 19.88b)
Debt / Equity = 0.80 (Debt 20.89b / last Quarter total Stockholder Equity 26.19b)
Debt / EBITDA = 3.48 (Net Debt 20.00b / EBITDA 6.00b)
Debt / FCF = 7.30 (Debt 20.89b / FCF TTM 2.86b)
Total Stockholder Equity = 26.69b (last 4 quarters mean)
RoA = 5.13% (Net Income 3.64b, Total Assets 71.02b )
RoE = 13.64% (Net Income TTM 3.64b / Total Stockholder Equity 26.69b)
RoCE = 10.43% (Ebit 4.67b / (Equity 26.69b + L.T.Debt 18.12b))
RoIC = 7.68% (NOPAT 3.55b / Invested Capital 46.19b)
WACC = 7.73% (E(79.89b)/V(100.78b) * Re(9.61%)) + (D(20.89b)/V(100.78b) * Rd(0.72%) * (1-Tc(0.24)))
Shares Correlation 3-Years: -100.00 | Cagr: -0.54%
Discount Rate = 9.61% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 72.28% ; FCFE base≈3.16b ; Y1≈3.07b ; Y5≈3.08b
Fair Price DCF = 32.47 (DCF Value 42.02b / Shares Outstanding 1.29b; 5y FCF grow -3.84% → 3.0% )
EPS Correlation: -6.50 | EPS CAGR: -0.49% | SUE: 1.24 | # QB: True
Revenue Correlation: 56.97 | Revenue CAGR: 5.46%
Additional Sources for MDLZ Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle